» Authors » Marie-Louise van der Hoorn

Marie-Louise van der Hoorn

Explore the profile of Marie-Louise van der Hoorn including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 23
Citations 211
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
El Emrani S, van der Hoorn M, Tan R, Steggerda S, de Vries L, Haak M, et al.
Arch Dis Child Fetal Neonatal Ed . 2025 Jan; PMID: 39870509
Objective: Fetomaternal transfusion (FMT) is associated with increased perinatal mortality and morbidity, but data on postnatal outcomes are scarce. Our aim was to determine the incidence of adverse short-termand long-term...
2.
Broekhuizen M, van der Hoorn M, Vadgama D, Eikmans M, Neecke B, Duvekot J, et al.
Eur J Immunol . 2025 Jan; 55(1):e202451386. PMID: 39821970
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in the placenta can lead to fetal distress and demise, characterized by severe trophoblast necrosis, chronic histiocytic intervillositis (CHI), and massive perivillous...
3.
Tajer P, Karakaslar E, Cante-Barrett K, Naber B, Vloemans S, van Eggermond M, et al.
Blood Adv . 2024 Jun; 8(18):4936-4947. PMID: 38916861
The curative benefits of autologous and allogeneic transplantation of hematopoietic stem cells (HSCs) have been proven in various diseases. However, the low number of true HSCs that can be collected...
4.
Mensink M, Verleng L, Schrama E, Janssen G, Tjokrodirijo R, Van Veelen P, et al.
JCI Insight . 2024 Feb; 9(5). PMID: 38341270
Tregs can facilitate transplant tolerance and attenuate autoimmune and inflammatory diseases. Therefore, it is clinically relevant to stimulate Treg expansion and function in vivo and to create therapeutic Treg products...
5.
Krop J, Tian X, van der Hoorn M, Eikmans M
Int J Mol Sci . 2023 Mar; 24(6). PMID: 36982375
Pregnancy is a fascinating immunological paradox: the semi-allogeneic fetus generally grows without any complications. In the placenta, fetal trophoblast cells come into contact with maternal immune cells. Inaccurate or inadequate...
6.
Bender Atik R, Christiansen O, Elson J, Kolte A, Lewis S, Middeldorp S, et al.
Hum Reprod Open . 2023 Mar; 2023(1):hoad002. PMID: 36873081
Study Question: What are the updates for the recommended management of women with recurrent pregnancy loss (RPL) based on the best available evidence in the literature from 2017 to 2022?...
7.
Tajer P, Cante-Barrett K, Naber B, Vloemans S, van Eggermond M, van der Hoorn M, et al.
Int J Mol Sci . 2022 Nov; 23(21). PMID: 36361533
The ex vivo expansion and maintenance of long-term hematopoietic stem cells (LT-HSC) is crucial for stem cell-based gene therapy. A combination of stem cell factor (SCF), thrombopoietin (TPO), FLT3 ligand...
8.
Youssef A, van der Hoorn M, van Eekelen R, van Geloven N, van Wely M, Smits M, et al.
BMJ Open . 2022 Sep; 12(9):e062402. PMID: 36153018
Introduction: Recurrent pregnancy loss (RPL) is defined as the loss of two or more conceptions before 24 weeks gestation. Despite extensive diagnostic workup, in only 25%-40% an underlying cause is...
9.
Eikmans M, Morales-Prieto D, van der Hoorn M, Markert U
Front Immunol . 2022 Aug; 13:983739. PMID: 35979367
No abstract available.
10.
van Bentem K, van der Hoorn M, van Lith J, le Cessie S, Lashley E
BMJ Open . 2022 Jul; 12(7):e059594. PMID: 35851011
Introduction: The assisted reproductive technique of oocyte donation (OD) is comparable to in vitro fertilisation (IVF), with the distinction of using a donated oocyte and thus involving two women. Compared...